Entera Bio (ENTX) Long-Term Deferred Tax (2021 - 2024)

Entera Bio (ENTX) has reported Long-Term Deferred Tax for 4 consecutive years, with $14000.0 the latest figure, recorded in Q3 2024.

• Quarterly Long-Term Deferred Tax fell 6.67% year-over-year to $14000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $14000.0 (down 6.67% YoY) and the FY2023 annual result came in at $14000.0, down 67.44% from the prior year.
• Long-Term Deferred Tax held at $14000.0 in Q3 2024 per ENTX's latest filing, from $14000.0 in the prior quarter.
• Over the last five years, Long-Term Deferred Tax for ENTX reached as high as $280000.0 in Q2 2022 and fell as low as $14000.0 in Q4 2023.
• A 4-year average of $84416.7 and a median of $43000.0 in 2022 frame the typical range for Long-Term Deferred Tax.
• Annual changes were most pronounced in 2023 — Long-Term Deferred Tax plunged 84.64% — and 2024, when it fell 6.67%.
• Year by year, Long-Term Deferred Tax stood at $217000.0 in 2021, then tumbled by 80.18% to $43000.0 in 2022, then tumbled by 67.44% to $14000.0 in 2023, then changed by 0.0% to $14000.0 in 2024.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $14000.0, $14000.0, and $14000.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.